Douglas Roblin to Bone Density Conservation Agents
This is a "connection" page, showing publications Douglas Roblin has written about Bone Density Conservation Agents.
Connection Strength
0.132
-
Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int. 2016 12; 27(12):3513-3524.
Score: 0.132